George Clinical takes over study management at start of Phase II as a rescue study.



When George Clinical was called upon to enter this Acute Myelogenous Leukemia Study in Elderly Patients at the start of Phase II, the client was dealing with a non-cooperative CRO, delays in site activation and low subject recruitment and enrollment activity. The sponsor team was also experiencing high turnover. This was a small study but required George Clinical to employ a full-service approach to the problems in order to build trust, improve communications and support a smooth transition from Phase I to Phase II.



Sponsor and George Clinical were not initially provided with documents/forms used in Phase I to support a smooth transition to Phase II. It was necessary to transition from a non-cooperative CRO who was providing no interaction with the client or with George Clinical. There were site activation delays, budget issues and insufficient subject recruitment and site engagement.


To download the complete case study, complete this form:


Free Download of the George Clinical Acute Myelogenous Leukemia Study



I wish to subscribe to George Clinical communications.